angiotensin ii has been researched along with ro 42-5892 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, M; Ganten, D; Ganten, U; Hilgenfeldt, U; Michel, JB; Paul, M; Ruf, P; Wagner, J; Zeh, K; Zimmermann, F | 1 |
| Brunner, HR; Camenzind, E; Coassolo, P; Fischli, W; Juillerat, L; Kleinbloesem, CH; Munafo, A; Nussberger, J; van Brummelen, P; Waeber, B | 1 |
| Branca, Q; Clozel, JP; el Amrani, K; Fischli, W; Neidhart, W; Stadler, H; Wostl, W | 1 |
| Bernadet, P; Chatellier, G; Guyene, TT; Kleinbloesem, CH; Ménard, J | 1 |
| Admiraal, PJ; Derkx, FH; Man in 't Veld, AJ; Mulder, P; Ritsema van Eck, HJ; Schalekamp, MA; van Brummelen, P; van den Meiracker, AH | 1 |
| el Amrani, AI; Gonzales, MF; Menard, J; Michel, JB | 1 |
| Azizi, M; Chatellier, G; Guyene, TT; Ménard, J | 1 |
| Fischli, W; Hilgers, KF; Mann, JF; Veelken, R | 1 |
| Admiraal, PJ; Derkx, FH; Kleinbloesem, C; Man in 't Veld, AJ; Mulder, P; Schalekamp, MA; van Brummelen, P; van den Meiracker, AH | 1 |
| Foote, EF; Halstenson, CE | 1 |
| Clozel, JP; Fischli, W | 1 |
| Clozel, JP; Fischli, W; Ménard, J | 1 |
1 review(s) available for angiotensin ii and ro 42-5892
| Article | Year |
|---|---|
New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Dipeptides; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Renin; Tetrazoles | 1993 |
5 trial(s) available for angiotensin ii and ro 42-5892
| Article | Year |
|---|---|
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Blood Pressure; Heart Rate; Humans; Imidazoles; Injections, Intravenous; Male; Renin; Single-Blind Method | 1991 |
Renin release regulation during acute renin inhibition in normal volunteers.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Blood Pressure; Heart Rate; Humans; Imidazoles; Infusions, Intravenous; Male; Renin | 1991 |
Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
Topics: Administration, Oral; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Drug Evaluation; Humans; Hypertension; Imidazoles; Injections, Intravenous; Male; Middle Aged; Renin; Time Factors | 1990 |
Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Topics: Administration, Oral; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Injections, Intravenous; Male; Middle Aged; Renin; Time Factors | 1994 |
Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Renin | 1993 |
6 other study(ies) available for angiotensin ii and ro 42-5892
| Article | Year |
|---|---|
Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Antisense Elements (Genetics); Blood Pressure; DNA; Heart Rate; Humans; Imidazoles; Kidney; Organ Specificity; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Transcription, Genetic | 1992 |
Ro 42-5892 is a potent orally active renin inhibitor in primates.
Topics: Administration, Oral; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Callitrichinae; Cattle; Cilazapril; Dogs; Dose-Response Relationship, Drug; Heart Rate; Humans; Imidazoles; Immunoradiometric Assay; Kidney; Minoxidil; Nephrectomy; Pyridazines; Rats; Regression Analysis; Renin; Saimiri; Sodium Chloride; Stereoisomerism | 1991 |
Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Guinea Pigs; Imidazoles; Kidney Function Tests; Lisinopril; Losartan; Male; Renal Circulation; Renin; Tetrazoles | 1993 |
Vascular renin in the guinea pig. Suppression by the renin inhibitor remikiren.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Vessels; Captopril; Chromatography, High Pressure Liquid; Guinea Pigs; Hindlimb; Imidazoles; Male; Radioimmunoassay; Renin | 1994 |
Comparative effects of three different potent renin inhibitors in primates.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Cilazapril; Dipeptides; Drug Interactions; Heart Rate; Humans; Imidazoles; In Vitro Techniques; Injections, Intravenous; Oligopeptides; Renin; Renin-Angiotensin System; Saimiri; Time Factors | 1993 |
Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Antibodies; Cilazapril; Cyclosporine; Female; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Male; Renin; Renin-Angiotensin System; Saimiri | 1993 |